日本透析医会(Japanese Association of Dialysis Physicians)
会長挨拶 役員名簿・組織図・委員会 定款・事業計画・事業報告 寄付のお願い
公募研究助成 研修セミナー 出版物 お知らせ
災害時情報ネットワーク 入会・変更・退会 会員用ログイン リンク
 2019 年 12 月以降に中国より発生した新型コロナウイルス感染症(COVID-19)は世界に蔓延し、 現在(2020年7月3日時点)では1000万人以上の感染者数となっています。
 COVID-19に関連した論文をPub Medで検査すると、28,492件(2020年7月3日時点) と非常に多くの論文がヒットします。
 この論文の中から、透析施設の医師やメディカルスタッフに有用と考えられる論文を選択して、 その要約をホームページで公開することにいたしました。
Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study
(2023/4/28掲載) NEW
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron Period
(オミクロン流行期の血液透析患者におけるmRNA COVID-19 ワクチン3 回接種の有効性)
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease A FIDELITY Pooled Secondary Analysis
(慢性腎臓病を合併した2 型糖尿病患者における、治療を要する肺炎および COVID-19関連有害事象発症とFinerenone 使用との関連 (FIDELITY 統合二次解析より))
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19
Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019
Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection
(SARS-CoV-2感染経過における家庭用抗原検査とRT-PCR およびウイルス培養の比較)
Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations
(医療施設における感染予防対策としての無症候者への SARS-CoV-2スクリーニング検査 、 課題と留意点)
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
(RECOVAC Immune-response Study: CKD,透析,腎移植患者における COVID-19 ワクチン接種の免疫原性,忍容性,安全性について)
Acute and postacute sequelae associated with SARS-CoV-2 reinfection
Prevalence of Positive Rapid Antigen Tests After 7-Day Isolation Following SARS-CoV-2 Infection in College Athletes During Omicron Variant Predominance
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review
(COVID-19 ワクチン接種がCOVID-19 後遺症発症と症状に及ぼす影響:系統的レビュー)
SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses
Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study
(ワクチン接種後の血液透析患者におけるCOVID-19 の重症度)
Associations of COVID-19 Outcomes with Dialysis Modalities and Settings
(透析モダリティおよび療養環境とCOVID-19 の予後との関連)
Impact of COVID-19 pandemic on hemodialysis access thrombosis
(血液透析患者のvascular access 血栓症へのCOCID19 の影響)
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
(オミクロン株BA.2.12.1、BA.4、BA.5 の各系統に対する 各種治療薬の効果について)
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination:Six months data from the observational Dia-Vacc study
(透析患者・腎移植後患者におけるSARS-Cov-2 mRNA ワクチン接種後の抗体価の 強力な低下のリスクについて:Dia-Vacc 前向き観察研究6か月後データより)
Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
(イスラエルにおける60歳以上の高齢者を対象としたBNT162b2ワクチンの4回接種と 3回接種の短期的な効果の比較:後ろ向き、診断陰性例、症例対照研究)
Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization:
A Systematic Review and Meta-analysis.

(外来COVID-19 患者における入院回避のためのフルボキサミン)
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
(ファイザー社新型コロナワクチンの4 回目接種の効果)
The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland
(スコットランドの腎不全患者(透析および移植)におけるSARS-CoV-2 感染(罹患と予後)に対するワクチンの効果)
Efficacy and safety of three new oral antiviral treatment (molnupiravir,fluvoxamine and Paxlovid) for COVID-19:a meta-analysis
(COVID-19 の3 種の経口薬(モルヌピラビル、フルボキサミン、パクスロビド)の有効性と安全性:メタ解析)
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis
Medical education and mental health during COVID-19: a survey across 9 countries
Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients
(血液透析患者のCOVID-19 予防に対するmRNAワクチン(BNT162b2)と アデノウイルスベクターワクチン(Ad26.COV2.S)の効果比較研究)
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19
(COVID-19 患者の呼吸不全に対する非侵襲的な酸素投与について)
Protection against Covid-19 by BNT162b2 Booster across Age Groups
(BNT162b2 ワクチンのブースター接種の全年齢層にわたるCOVID-19 に対する予防効果)
Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis
(血液透析患者におけるBNT162b2とmRNA-1273 SARS-CoV-2ワクチンの リアルワールドでの有効性と免疫原性)
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK(COV-BOOST) :  a blinded, multicentre, randomised, controlled, phase 2 trial
(ChAdOx1 nCov-19またはBNT162b2の2回の接種後に3回目の投与として 異なるCOVID-19ワクチンを投与した場合の安全性と免疫原性の比較   (COV-BOOST試験: 第II相多施設共同無作為化試験) )
Serum ferritin as a predictive biomarker in COVID-19.
 A systematic review, meta-analysis and meta-regression analysis.

(COVID-19 の予測バイオマーカーとしての血清フェリチン
   ― 系統的レビュー、メタ分析、メタ回帰分析 ―)

Survival and Predictive Factors in Dialysis Patients with COVID-19 in Japan :
A Nationwide Cohort Study

Waning Immunity after the BNT162b2 Vaccine in Israel
(イスラエルでのBNT162b2 ワクチン接種後の免疫力の低下)
Steroids Use in Non-Oxygen requiring COVID-19 Patients: A Systematic Review and Meta-analysis.
(酸素投与を必要としないCOVID-19 患者における副腎皮質ステロイド使用:システマティックレビューとメタ解析)
Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients
(ロンドンの血液透析患者におけるCOVID-19 疾患のリスク、透析施設の属性、および感染制御戦略)
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines with Confirmatory Testing in a US Regional Health System
(mRNA COVID-19 ワクチンのアレルギーおよびアナフィラキシー反応の評価)
The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis
(SARS-CoV-2 未感染の血液透析患者におけるSARS-CoV-2 mRNA ワクチンに対する液性および細胞性免疫反応)
Trajectories of clinical and laboratory characteristics associated with COVID-19 in hemodialysis patients by survival
Therapeutic plasma exchange in patients with life-threatening COVID-19:
a randomized controlled clinical trial

(COVID-19 に対する血漿交換の有効性について)
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
(軽度と中等度のCOVID-19に対するBamlanivimab + Etesevimabの効果)
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
(D-ダイマー濃度上昇を認めたCOVID-19 入院患者に対する治療的抗凝固療法と予防的抗凝固療法の比較)
Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis
(維持透析患者における抗体、病歴とCOVID-19 の罹患)
Humoral Response after SARS-Cov-2 mRNA Vaccine in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
(血液透析および腎移植患者を対象としたSARS-Cov-2 mRNA ワクチン接種後の液性反応)
Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure
(腎不全患者におけるレニン・アンジオテンシン系阻害薬とCOVID-19 関連死亡のリスク)
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
(COVID-19 肺炎の入院患者に対するトファシチニブの効果)
Epidemiology and Outcomes of COVID-19 in Home Dialysis Patients Compared with In-Center Dialysis Patients.
(在宅透析患者と施設透析患者におけるCOVID-19 の予後と疫学についての比較)
Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis
ChAdOx1 nCoV-19ワクチン後の血栓症・血小板減少症 (2021/6/8掲載)
Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance
 (維持血液透析中のCOVID-19 患者におけるレムデシビルの使用:安全性と忍容性)
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
 (B.1.351変異株に対するChAdOx1 nCoV-19 ワクチンの有効性)
Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic.    An after action review from a UK tertiary critical care centre
 (COVID-19パンデミック時の重症患者の急性腎障害に対する3つの 腎代替療法(持続的血液濾過透析、腹膜透析、血液透析)の提供)
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
 (維持血液透析患者におけるファイザー社BNT162b2 ワクチンの液性免疫反応)
Initial Effects of COVID-19 on Patients with ESKD
 (ESKD 患者に対するCOVID-19 の初期効果)
Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients
- a prospective cohort study

 (透析患者におけるファイザー社のmRNA ワクチン接種後の抗体保有率)
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
 (血液透析患者におけるSARS-CoV-2 感染への免疫反応の持続性と再感染に対する予防効果)
The Impact of COVID‐19 on the mental health of dialysis patients
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
 (ICU に入室した重症COVID-19患者における静脈血栓塞栓症と大出血、 早期の抗凝固療法の効果についての大規模観察研究)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
 (BNT162b2 mRNA COVID-19ワクチン効果の国家規模での調査)
6-month consequences COVID-19 in patients discharged from hospital: a cohort
Covid-19患者に対するトシリズマブの効果  〜2つの臨床試験の結果から〜
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
 (ファイザー社のメッセンジャーRNA ワクチンの効果と副反応を報告した論文)
Effect of Discontinuing vs Continuing Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID‐19
 (COVID-19 入院患者におけるRAS 阻害薬の中止と継続の効果の比較)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
 (COVID-19 に対する実験的治療:非盲検対照研究)
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
 (COVID-19と季節性インフルエンザの比較 背景情報・罹患率・致死率 ―国民データベースによる後ろ向きコーホート研究―)
腹膜透析患者のケースシリーズ研究 (2021/2/2掲載)
COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider
 (米国透析患者におけるCOVID-19 の危険因子と予後)
Targeting COVID‐19 prevention in hemodialysis facilities is associated with a drastic reduction in central venous catheter‐related infections
Prevalence of SARS-CoV-2 antibodies in a large Nationwide sample of patients on dialysis in the USA: a cross-sectional study.
 (米国の透析患者の血清を用いてSARS-CoV-2に対する抗体陽性率を調査し、 患者属性ごとの特徴を調べた横断研究)
Characteristics and Outcomes of Individuals With Preexisting Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility
 (ベルギーの血液透析施設における SARS-CoV-2感染者の3か月間にわたる血清学的抗体価の推移 )
Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection
(SARS-CoV-2感染入院患者における血清25(OH)D 濃度) (2020/12/1掲載)
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
欧米の腎不全患者におけるCOVID-19 の発生率と致死率について (2020/11/3掲載)
Remdesivir for Adults With COVID-19 : A Living Systematic Review for an American College of Physicians Practice Point
(COVID-19 成人患者へのレムデシビル治療:リビングシステマティックレビュー)
The keys to control a COVID-19 outbreak in a haemodialysis unit
(透析ユニットでのCOVID-19 をコントロールするための鍵)
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
(唾液検体と鼻咽頭検体によるSARS-CoV-2 の定量測定)
Temporal dynamics in viral shedding and transmissibility of COVID-19
(COVID-19 のウイルス放出と伝染性がいつから始まるのか?)
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report
(SARS-CoV-2 に対するmRNA ワクチンのフェーズ1 試験)
SARS‐CoV‐2 in the peritoneal waste in a patient treated with peritoneal dialysis.
COVID‐19 Outbreak in an Urban Hemodialysis Unit
Clinical Characteristics of and Medical Interventions for COVID‐19 in Hemodialysis Patients in Wuhan, China
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
(COVID-19 の診断と予後における予測モデル)
High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.
(SARS-CoV-2 に感染した血液透析患者の臨床的特徴と短期予後
〜Brescia Renal COVID Task Force からの報告〜)
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report
(COVID-19 入院患者に対するデキサメタゾンの効果)
Presentation and Outcomes of Patients with ESKD and COVID-19
False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications
(SARS-CoV-2感染に対する偽陰性検査結果 − その難しさと意味するもの)
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

お知らせ 新型コロナ関連 COVID-19関連の症例報告